Kenilworth-based Merck & Co. announced it is slashing 500 jobs in several states.
In a statement, the company said that the Worker Adjustment and Retraining Notification (WARN) it received on Wednesday is in regard to several changes in its U.S. commercial organization.
“Approximately 500 people will be affected in select sales and headquarters commercial teams. The roles being eliminated are located across all states; but for administrative purposes, the jobs are associated with Merck’s U.S. [Human Health and Merck Research Laboratories] headquarters in Upper Gwynedd, Pa. Employees whose jobs are impacted by these changes can apply to other open positions at Merck,” the statement said.
A small percentage of jobs are being cut in New Jersey.
Impacted employees who are not placed in a role will be offered a comprehensive separation package and will separate from Merck on Jan. 3, 2020.
At the same time Merck said that it is eliminating certain U.S. jobs, they are also adding new U.S. jobs in growth areas, such as oncology, based on changes in its portfolio.
“This is not a new restructuring effort; these changes are part of ongoing company-wide efforts to sharpen Merck’s focus on innovative research and development that addresses significant unmet medical needs and on our best opportunities for growth.”